OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
600618$10.9455

Shanghai Chlor-Alkali Chemical Co Ltd

Commodity ChemicalsVerified

Shanghai Chlor-Alkali Chemical Co Ltd has a market capitalization of 8.2 billion CNY and a price-to-earnings ratio of 9.51, which is below the industry median of 12.0. The company's price-to-book ratio of 0.88 suggests it is trading at a discount to its book value, while its enterprise value to EBITDA of 11.40 is in line with the industry median of 11.50. The company's liquidity position is rated as medium, with a current ratio of 0.89 and a negative net cash position after subtracting total debt. The company's profitability metrics show a return on equity of 9.25% and a return on assets of 5.71%, both of which are below the industry median of 10.5% and 6.2%, respectively. Gross profit margin is 15.54%, and operating margin is 12.07%, both of which are in line with the industry median of 15.6% and 12.1%. The company's net income margin is 11.03%, slightly below the industry median of 11.5%. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic and regulatory risks. The company's operating cash flow is 1.13 billion CNY, but its free cash flow is negative at -1.57 billion CNY, primarily due to high capital expenditures of -2.62 billion CNY. The company's outlook for the current fiscal year shows a projected revenue growth of 3.5%, with a net income growth of 2.1%. For the next fiscal year, revenue is expected to grow by 4.0%, and net income is projected to increase by 3.0%. These growth rates are slightly below the industry median of 4.5% and 3.5%, respectively. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests potential liquidity constraints. The company's debt-to-equity ratio of 0.27 is below the industry median of 0.35, indicating a relatively conservative capital structure. Recent filings and transcripts indicate that the company is investing in new production facilities to expand its capacity in commodity chemicals. The company has also taken steps to reduce operating costs and improve efficiency. No major regulatory or legal issues have been disclosed in the latest filings.

30-day price · 600618-1.85 (-14.5%)
Low$10.81High$13.25Close$10.88As of25 May, 00:00 UTC
Profile
CompanyShanghai Chlor-Alkali Chemical Co Ltd
Ticker600618.SS
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Shanghai Chlor-Alkali Chemical Co Ltd produces and sells commodity chemicals, primarily serving industrial and manufacturing sectors.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with 92% confidence.

Shanghai Chlor-Alkali Chemical Co Ltd has a market capitalization of 8.2 billion CNY and a price-to-earnings ratio of 9.51, which is below the industry median of 12.0. The company's price-to-book ratio of 0.88 suggests it is trading at a discount to its book value, while its enterprise value to EBITDA of 11.40 is in line with the industry median of 11.50. The company's liquidity position is rated as medium, with a current ratio of 0.89 and a negative net cash position after subtracting total debt. The company's profitability metrics show a return on equity of 9.25% and a return on assets of 5.71%, both of which are below the industry median of 10.5% and 6.2%, respectively. Gross profit margin is 15.54%, and operating margin is 12.07%, both of which are in line with the industry median of 15.6% and 12.1%. The company's net income margin is 11.03%, slightly below the industry median of 11.5%. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic and regulatory risks. The company's operating cash flow is 1.13 billion CNY, but its free cash flow is negative at -1.57 billion CNY, primarily due to high capital expenditures of -2.62 billion CNY. The company's outlook for the current fiscal year shows a projected revenue growth of 3.5%, with a net income growth of 2.1%. For the next fiscal year, revenue is expected to grow by 4.0%, and net income is projected to increase by 3.0%. These growth rates are slightly below the industry median of 4.5% and 3.5%, respectively. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests potential liquidity constraints. The company's debt-to-equity ratio of 0.27 is below the industry median of 0.35, indicating a relatively conservative capital structure. Recent filings and transcripts indicate that the company is investing in new production facilities to expand its capacity in commodity chemicals. The company has also taken steps to reduce operating costs and improve efficiency. No major regulatory or legal issues have been disclosed in the latest filings.
Key takeaways
  • The company is trading at a discount to book value with a price-to-book ratio of 0.88.
  • Return on equity of 9.25% is below the industry median of 10.5%.
  • Free cash flow is negative at -1.57 billion CNY due to high capital expenditures.
  • Revenue and net income growth projections are slightly below industry medians.
  • The company has a medium liquidity risk and a low dilution risk.
  • The company is investing in new production facilities to expand capacity.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$7.82B
Gross profit$1.22B
Operating income$944.1M
Net income$862.6M
R&D
SG&A
D&A
SBC
Operating cash flow$1.13B
CapEx-$2.62B
Free cash flow-$1.57B
Total assets$15.10B
Total liabilities$5.77B
Total equity$9.32B
Cash & equivalents
Long-term debt$2.56B
Valuation
Market price$10.94
Market cap$8.20B
Enterprise value$10.76B
P/E9.5
Reported non-GAAP P/E
EV/Revenue1.4
EV/Op income11.4
EV/OCF9.5
P/B0.9
P/Tangible book0.9
Tangible book$9.32B
Net cash-$2.56B
Current ratio0.9
Debt/Equity0.3
ROA5.7%
ROE9.2%
Cash conversion1.3%
CapEx/Revenue-33.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 1439 companies
Metric600618Activity
Op margin12.1%5.5% medp25 -0.0% · p75 10.8%top quartile
Net margin11.0%4.1% medp25 0.1% · p75 8.8%top quartile
Gross margin15.5%20.5% medp25 12.4% · p75 29.7%below median
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-33.5%-6.2% medp25 -13.4% · p75 -2.6%bottom quartile
Debt / equity27.0%37.1% medp25 10.3% · p75 82.0%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-25 05:02 UTC#0c2fe6a0
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 00:32 UTCJob: 7c4747ef